Rating Change
Cantor Fitzgerald analysts reiterated a Neutral rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 06, 2026.
reiterateNYSE:BMY
Cantor Fitzgerald Reiterates Neutral Rating on Bristol-Myers Squibb Company (BMY)
Rating Change Cantor Fitzgerald analysts reiterated a Neutral rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 06, 2026. Market Context Bristol-Myers Squibb Company…
Market Context
Bristol-Myers Squibb Company operates in the Healthcare sector. The stock currently trades at $56.70 with a market capitalization of $104.2B. The stock has gained 22.0% over the past 52 weeks.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Bristol-Myers Squibb Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Bristol-Myers Squibb Company
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 06, 2026 | Cantor Fitzgerald | Neutral | N/A |
| Apr 09, 2026 | B of A Securities | Buy | N/A |
| Apr 08, 2026 | Cantor Fitzgerald | Neutral | N/A |
| Apr 08, 2026 | Guggenheim | Buy | N/A |
| Mar 17, 2026 | HSBC | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View BMY Stock Page
Frequently Asked Questions
What does a Neutral rating mean for BMY?
A Neutral rating from Cantor Fitzgerald reflects the analyst's outlook on Bristol-Myers Squibb Company (NYSE:BMY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BMY forecast page.
